Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
DUBLIN - March 13, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Oppenheimer 28th Annual Healthcare Conference on Tuesday,...
DUBLIN - March 12, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that applications are now being accepted for the 2018 Medtronic Global Champions team....
DUBLIN - March 12, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received U.S. Food and Drug Administration (FDA) approval...
DUBLIN and ORLANDO - March 10, 2018 - Medtronic plc (NYSE: MDT) today unveiled outcomes from the CoreValve U.S. Pivotal Extreme Risk Study and the real-world NOTION trial (Nordic Aortic Valve...
DUBLIN - March 9, 2018 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 fourth quarter cash dividend of $0.46 per ordinary share, representing a 7 percent...
DUBLIN - March 9, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will answer questions about the company on Wednesday, March 14, 2018, in Miami, Florida.
DUBLIN - March 8, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 38th Annual Cowen and Company Healthcare Conference on...
LEHIGH VALLEY, Pa. and DUBLIN - February 28, 2018 - Today, Medtronic plc (NYSE: MDT), the global leader in medical technology, and Lehigh Valley Health Network (LVHN), an eight-hospital network...
DUBLIN- February 26, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has approved a new arm indication...
DUBLIN - February 26, 2018 - Designed specifically for small vessels, Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute...